Humana Inc. (NYSE:HUM) Shares Purchased by Ridgewood Investments LLC

Ridgewood Investments LLC increased its position in shares of Humana Inc. (NYSE:HUM) by 15.8% in the fourth quarter, HoldingsChannel reports. The firm owned 1,026 shares of the insurance provider’s stock after acquiring an additional 140 shares during the quarter. Ridgewood Investments LLC’s holdings in Humana were worth $260,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently bought and sold shares of the stock. Wealth Enhancement Advisory Services LLC lifted its holdings in Humana by 1.6% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 8,848 shares of the insurance provider’s stock valued at $2,245,000 after acquiring an additional 138 shares during the period. First Hawaiian Bank increased its position in shares of Humana by 55.1% during the fourth quarter. First Hawaiian Bank now owns 12,647 shares of the insurance provider’s stock worth $3,209,000 after purchasing an additional 4,494 shares in the last quarter. Nordea Investment Management AB increased its position in shares of Humana by 6.6% during the fourth quarter. Nordea Investment Management AB now owns 9,679 shares of the insurance provider’s stock worth $2,487,000 after purchasing an additional 602 shares in the last quarter. Central Pacific Bank Trust Division increased its position in shares of Humana by 110.7% during the fourth quarter. Central Pacific Bank Trust Division now owns 2,950 shares of the insurance provider’s stock worth $748,000 after purchasing an additional 1,550 shares in the last quarter. Finally, Everence Capital Management Inc. increased its position in shares of Humana by 57.5% during the fourth quarter. Everence Capital Management Inc. now owns 5,530 shares of the insurance provider’s stock worth $1,403,000 after purchasing an additional 2,020 shares in the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on HUM. Stephens restated an “equal weight” rating and issued a $250.00 target price on shares of Humana in a report on Wednesday, October 9th. Leerink Partnrs lowered Humana from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Truist Financial increased their target price on Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research note on Monday. Oppenheimer decreased their target price on Humana from $400.00 to $280.00 and set an “outperform” rating on the stock in a research note on Thursday, October 3rd. Finally, Wells Fargo & Company reduced their price target on Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a research report on Monday, November 4th. Twenty analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $302.00.

Humana Stock Performance

Shares of HUM stock traded up $4.22 during midday trading on Friday, hitting $272.35. The company had a trading volume of 440,720 shares, compared to its average volume of 1,029,989. The company’s 50 day simple moving average is $273.07 and its 200 day simple moving average is $311.56. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $459.76. The stock has a market cap of $32.79 billion, a price-to-earnings ratio of 24.12, a PEG ratio of 2.12 and a beta of 0.55. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The firm had revenue of $29.30 billion for the quarter, compared to the consensus estimate of $28.66 billion. Research analysts anticipate that Humana Inc. will post 16.14 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be given a dividend of $0.885 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a yield of 1.30%. Humana’s payout ratio is 31.36%.

Insiders Place Their Bets

In other news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the sale, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.32% of the stock is owned by company insiders.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.